| PERIOD ENDING | 30-Aug-09 | 10-May-09 | 15-Feb-09 | 23-Nov-08 | | Total Revenue | 22,378,000 | 15,806,000 | 16,843,000 | 16,395,000 | | Cost of Revenue | 19,512,000 | 13,776,000 | 14,771,000 | 14,276,000 | | | Gross Profit | 2,866,000 | 2,030,000 | 2,072,000 | 2,119,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,254,000 | 1,655,000 | 1,666,000 | 1,677,000 | | Non Recurring | 14,000 | 16,000 | 8,000 | 20,000 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 598,000 | 359,000 | 398,000 | 422,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 15,000 | 16,000 | (4,000) | 18,000 | | Earnings Before Interest And Taxes | 613,000 | 363,000 | 406,000 | 440,000 | | Interest Expense | 33,000 | 25,000 | 25,000 | 25,000 | | Income Before Tax | 580,000 | 338,000 | 381,000 | 415,000 | | Income Tax Expense | 206,000 | 128,000 | 142,000 | 152,000 | | Minority Interest |
-
| 2,000 | (2,000) |
-
| | | | Net Income From Continuing Ops | 374,000 | 210,000 | 239,000 | 263,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 374,000 | 210,000 | 239,000 | 263,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $374,000 | $210,000 | $239,000 | $263,000 |
|
1.27% Nasdaq 
Income Statement
